BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Niu MY, Dong GT, Li Y, Luo Q, Cao L, Wang XM, Wang QW, Wang YT, Zhang Z, Zhong XW, Dai WB, Li LY. Fanlian Huazhuo Formula alleviates high-fat diet-induced non-alcoholic fatty liver disease by modulating autophagy and lipid synthesis signaling pathway. World J Gastroenterol 2024; 30(30): 3584-3608 [PMID: 39193572 DOI: 10.3748/wjg.v30.i30.3584]
URL: https://www.wjgnet.com/1007-9327/full/v30/i30/3584.htm
Number Citing Articles
1
Santiago Rodriguez, Maria Luiza Fernandes Dahlem, Carina Rossoni, Norma P Marroni, Claudio A Marroni, Sabrina Alves Fernandes. Nutrients as epigenetic modulators in metabolic dysfunction-associated steatotic liver diseaseWorld Journal of Hepatology 2025; 17(8): 108182 doi: 10.4254/wjh.v17.i8.108182
2
Bhupesh Singla. Fanlian Huazhuo Formula: A promising herbal preparation for metabolic liver diseaseWorld Journal of Gastroenterology 2024; 30(46): 4964-4968 doi: 10.3748/wjg.v30.i46.4964
3
Lu Jiang, Jian-Gao Fan. Gut microbiota in gastrointestinal diseases: Insights and therapeutic strategiesWorld Journal of Gastroenterology 2024; 30(39): 4329-4332 doi: 10.3748/wjg.v30.i39.4329
4
Chun-Han Cheng, Wen-Rui Hao, Tzu-Hurng Cheng. Fanlian Huazhuo formula: A promising therapeutic approach for metabolic associated steatotic liver diseaseWorld Journal of Gastroenterology 2025; 31(1): 100250 doi: 10.3748/wjg.v31.i1.100250
5
Wen-Yi Nie, Yang Ye, Hong-Xuan Tong, Jing-Qing Hu. Herbal medicine as a potential treatment for non-alcoholic fatty liver diseaseWorld Journal of Gastroenterology 2025; 31(9): 100273 doi: 10.3748/wjg.v31.i9.100273
6
Wen-Yige Zhang, Meng-Hui Wang, Chuan Xie. Potential of traditional Chinese medicine in the treatment of nonalcoholic fatty liver disease: A promising futureWorld Journal of Gastroenterology 2024; 30(43): 4597-4601 doi: 10.3748/wjg.v30.i43.4597